Aroa Biosurgery Limited (AROAF)
OTCMKTS · Delayed Price · Currency is USD
0.3500
0.00 (0.00%)
Aug 19, 2025, 4:00 PM EDT
Aroa Biosurgery Revenue
In the fiscal year ending March 31, 2025, Aroa Biosurgery had annual revenue of 84.70M NZD with 22.63% growth. Aroa Biosurgery had revenue of 45.54M in the half year ending March 31, 2025, with 33.85% growth.
Revenue
84.70M NZD
Revenue Growth
+22.63%
P/S Ratio
2.96
Revenue / Employee
n/a
Employees
n/a
Market Cap
142.24M USD
Revenue Chart
* This company reports financials in NZD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 84.70M | 15.63M | 22.63% |
| Mar 31, 2024 | 69.07M | 5.71M | 9.01% |
| Mar 31, 2023 | 63.36M | 23.68M | 59.68% |
| Mar 31, 2022 | 39.68M | 17.34M | 77.60% |
| Mar 31, 2021 | 22.34M | -2.73M | -10.90% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |